Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
| Autor: | Edison Roberto Parise, Norberto C. Chávez-Tapia, Claudia P. Oliveira, Walter Masson, Juan Pablo Arab, Marco Arrese, Arturo Panduro, Adrián Gadano, Nahum Méndez-Sánchez, Marlene Perez, Andrés Ruf, Marlene Castellanos-Fernandez, Eduardo Vilar-Gomez, Daniela Chiodi, Javier Diaz, Sebastián Marciano, Jaime Poniachik, Juan Carlos Restrepo, Helma Pinchemel Cotrim, Marcos Girala, Mário Reis Álvares-da-Silva, Kenneth Cusi, José E Costa Gil, Adelina Lozano, Marcelo Silva, Solange Gerona, Carlos Benítez, Martín Tagle, Kenia Torres, Francisco Barrera, Melisa Dirchwolf, Graciela Castro-Narro, Nelia Hernández, Nathalie C. Leite, Raymundo Paraná, Eduardo Fassio, Martín Padilla, Monica Tapias |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Clinical practice guidance Cirrhosis Steatosis medicine.medical_treatment Population Specialties of internal medicine MAFLD Disease Liver transplantation Chronic liver disease 03 medical and health sciences 0302 clinical medicine Non-alcoholic Fatty Liver Disease NAFLD Fatty liver Nonalcoholic fatty liver disease medicine Humans Nonalcoholic steatohepatitis education Intensive care medicine education.field_of_study Hepatology business.industry purl.org/pe-repo/ocde/ford#3.02.19 [https] NASH nutritional and metabolic diseases General Medicine Guideline medicine.disease digestive system diseases Latin America RC581-951 030220 oncology & carcinogenesis 030211 gastroenterology & hepatology business Algorithms |
| Zdroj: | Annals of Hepatology, Vol 19, Iss 6, Pp 674-690 (2020) |
| Popis: | Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence is predicted to increase exponentially in the next decades, concomitantly with the global epidemic of obesity, type 2 diabetes mellitus (T2DM), and sedentary lifestyle. NAFLD is a clinical syndrome that encompasses a wide spectrum of associated diseases and hepatic complications such as hepatocellular carcinoma (HCC). Moreover, this disease is believed to become the main indication for liver transplantation in the near future. Since NAFLD management represents a growing challenge for primary care physicians, the Asociación Latinoamericana para el Estudio del Hígado (ALEH) has decided to organize this Practice Guidance for the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease, written by Latin-American specialists in different clinical areas, and destined to general practitioners, internal medicine specialists, endocrinologists, diabetologists, gastroenterologists, and hepatologists. The main purpose of this document is to improve patient care and awareness of NAFLD. The information provided in this guidance may also be useful in assisting stakeholders in the decision-making process related to NAFLD. Since new evidence is constantly emerging on different aspects of the disease, updates to this guideline will be required in future. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|